NSCLC With COPD
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab as First-line Treatment for Advanced NSCLC Complicated With COPD (NCT05578222) | Tianjin Chest Hospital | 2022-10-10 |
Track NSCLC With COPD automatically
Every clearance here is in the API, with alerts when new ones post.